Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Synlogic Announces Progress Toward 2022 Clinical Milestones and Participation at Upcoming Investor Conferences Read more about Synlogic Announces Progress Toward 2022 Clinical Milestones and Participation at Upcoming Investor Conferences Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618 Read more about Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618 Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting Read more about Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting Synlogic Reports Third Quarter Financial Results and Provides Business Update Read more about Synlogic Reports Third Quarter Financial Results and Provides Business Update Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria Read more about Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria Synlogic Announces Third Quarter 2021 Conference Call & Participation in Upcoming Banking Conference Read more about Synlogic Announces Third Quarter 2021 Conference Call & Participation in Upcoming Banking Conference Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria Read more about Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021 Read more about Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021 Synlogic Announces Nature Publication Demonstrating Novel Application of Synthetic Biotic Platform Read more about Synlogic Announces Nature Publication Demonstrating Novel Application of Synthetic Biotic Platform Synlogic Appoints Molly Harper as Chief Business Officer Read more about Synlogic Appoints Molly Harper as Chief Business Officer Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Current page 7 Page 8 Page 9 Page 10 Page 11 … Next page Next › Last page Last » Subscribe to Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic Announces Progress Toward 2022 Clinical Milestones and Participation at Upcoming Investor Conferences Read more about Synlogic Announces Progress Toward 2022 Clinical Milestones and Participation at Upcoming Investor Conferences
Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618 Read more about Synlogic Presents Data Demonstrating Reductions in Plasma Phenylalanine Levels in Patients with Phenylketonuria Treated with SYNB1618
Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting Read more about Synlogic Announces Presentation of Phenylketonuria Data at 14th International Congress of Inborn Errors of Metabolism Meeting
Synlogic Reports Third Quarter Financial Results and Provides Business Update Read more about Synlogic Reports Third Quarter Financial Results and Provides Business Update
Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria Read more about Synlogic and Ginkgo Bioworks Announce Investigational Synthetic Biotic Medicine for the Treatment of Homocystinuria
Synlogic Announces Third Quarter 2021 Conference Call & Participation in Upcoming Banking Conference Read more about Synlogic Announces Third Quarter 2021 Conference Call & Participation in Upcoming Banking Conference
Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria Read more about Synlogic Announces Nature Communications Publication Highlighting Use of Synthetic Biotic Platform to Optimize Therapies for Phenylketonuria
Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021 Read more about Synlogic Presents Data on Hyperoxaluria Program at American Society of Nephrology Kidney Week 2021
Synlogic Announces Nature Publication Demonstrating Novel Application of Synthetic Biotic Platform Read more about Synlogic Announces Nature Publication Demonstrating Novel Application of Synthetic Biotic Platform
Synlogic Appoints Molly Harper as Chief Business Officer Read more about Synlogic Appoints Molly Harper as Chief Business Officer